Treatment of murine melanoma with IL-32 improved dendritic cell function and triggered M1 polarization as well as CCL5 release in macrophages, resulting in CCR5-mediated CD8 + T cell infiltration into the tumor microenvironment and the eradication of cancer cells [19]. Here, IL32 is linked to melanoma.